Sputnik V, the Russian vaccine candidate for Covid-19, will undergo phase-III clinical trials in India. Dr. Reddy's Laboratories Ltd, a pharmaceutical company headquartered in the southern city of Hyderabad, has partnered with the Russian Direct Investment Fund, a sovereign wealth fund, to conduct the trials and distribution of the vaccine candidate in India. Sputnik V […]
The post Russia’s Covid Vaccine Candidate Sputnik V to Have Clinical Trials in India appeared first on L.A. Focus Newspaper.